These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24213809)

  • 1. Deciphering the role of Burkholderia cenocepacia membrane proteins in antimicrobial properties of chitosan.
    Ibrahim M; Tao Z; Hussain A; Chunlan Y; Ilyas M; Waheed A; Yuan F; Li B; Xie GL
    Arch Microbiol; 2014 Jan; 196(1):9-16. PubMed ID: 24213809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the role of RND efflux transporters in Burkholderia cenocepacia.
    Bazzini S; Udine C; Sass A; Pasca MR; Longo F; Emiliani G; Fondi M; Perrin E; Decorosi F; Viti C; Giovannetti L; Leoni L; Fani R; Riccardi G; Mahenthiralingam E; Buroni S
    PLoS One; 2011 Apr; 6(4):e18902. PubMed ID: 21526150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.
    Guglierame P; Pasca MR; De Rossi E; Buroni S; Arrigo P; Manina G; Riccardi G
    BMC Microbiol; 2006 Jul; 6():66. PubMed ID: 16857052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells.
    Buroni S; Matthijs N; Spadaro F; Van Acker H; Scoffone VC; Pasca MR; Riccardi G; Coenye T
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7424-9. PubMed ID: 25267676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.
    Bazzini S; Udine C; Riccardi G
    Appl Microbiol Biotechnol; 2011 Dec; 92(5):887-95. PubMed ID: 21997606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes.
    Loutet SA; Di Lorenzo F; Clarke C; Molinaro A; Valvano MA
    BMC Genomics; 2011 Sep; 12():472. PubMed ID: 21955326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Burkholderia cenocepacia(†).
    Hamad MA; Di Lorenzo F; Molinaro A; Valvano MA
    Mol Microbiol; 2012 Sep; 85(5):962-74. PubMed ID: 22742453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia.
    Scoffone VC; Spadaro F; Udine C; Makarov V; Fondi M; Fani R; De Rossi E; Riccardi G; Buroni S
    Antimicrob Agents Chemother; 2014; 58(4):2415-7. PubMed ID: 24395233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms.
    Coenye T; Van Acker H; Peeters E; Sass A; Buroni S; Riccardi G; Mahenthiralingam E
    Antimicrob Agents Chemother; 2011 May; 55(5):1912-9. PubMed ID: 21357299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia.
    Gislason AS; Choy M; Bloodworth RA; Qu W; Stietz MS; Li X; Zhang C; Cardona ST
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy.
    Madeira A; Santos PM; Coutinho CP; Pinto-de-Oliveira A; Sá-Correia I
    Proteomics; 2011 Apr; 11(7):1313-28. PubMed ID: 21337515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the mechanism behind the potentiating activity of baicalin against Burkholderia cenocepacia biofilms.
    Slachmuylders L; Van Acker H; Brackman G; Sass A; Van Nieuwerburgh F; Coenye T
    PLoS One; 2018; 13(1):e0190533. PubMed ID: 29293658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BpeB, a major resistance-nodulation-cell division transporter from Burkholderia cenocepacia: construct design, crystallization and preliminary structural analysis.
    Horikawa T; Hung LW; Kim HB; Shaya D; Kim CY; Terwilliger TC; Yamashita E; Aoki M; Okada U; Murakami S
    Acta Crystallogr F Struct Biol Commun; 2018 Nov; 74(Pt 11):710-716. PubMed ID: 30387776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the genome diversity and virulence of two clinical isolates of Burkholderia cenocepacia.
    Salloum T; Nassour E; Araj GF; Abboud E; Tokajian S
    J Med Microbiol; 2018 Aug; 67(8):1157-1167. PubMed ID: 29897328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein profiling analyses of the outer membrane of Burkholderia cenocepacia reveal a niche-specific proteome.
    Liu H; Ibrahim M; Qiu H; Kausar S; Ilyas M; Cui Z; Hussain A; Li B; Waheed A; Zhu B; Xie G
    Microb Ecol; 2015 Jan; 69(1):75-83. PubMed ID: 25081413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo.
    Loutet SA; Flannagan RS; Kooi C; Sokol PA; Valvano MA
    J Bacteriol; 2006 Mar; 188(6):2073-80. PubMed ID: 16513737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
    Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia.
    Selin C; Stietz MS; Blanchard JE; Gehrke SS; Bernard S; Hall DG; Brown ED; Cardona ST
    PLoS One; 2015; 10(6):e0128587. PubMed ID: 26053039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. σ54-Dependent Response to Nitrogen Limitation and Virulence in Burkholderia cenocepacia Strain H111.
    Lardi M; Aguilar C; Pedrioli A; Omasits U; Suppiger A; Cárcamo-Oyarce G; Schmid N; Ahrens CH; Eberl L; Pessi G
    Appl Environ Microbiol; 2015 Jun; 81(12):4077-89. PubMed ID: 25841012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A markerless deletion method for genetic manipulation of Burkholderia cenocepacia and other multidrug-resistant gram-negative bacteria.
    Aubert DF; Hamad MA; Valvano MA
    Methods Mol Biol; 2014; 1197():311-27. PubMed ID: 25172289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.